TWI286159B - Improved stability of hybridisation interactions in dipstick assays - Google Patents
Improved stability of hybridisation interactions in dipstick assays Download PDFInfo
- Publication number
- TWI286159B TWI286159B TW90116567A TW90116567A TWI286159B TW I286159 B TWI286159 B TW I286159B TW 90116567 A TW90116567 A TW 90116567A TW 90116567 A TW90116567 A TW 90116567A TW I286159 B TWI286159 B TW I286159B
- Authority
- TW
- Taiwan
- Prior art keywords
- nucleic acid
- probe
- target nucleic
- capture
- detection
- Prior art date
Links
- 238000003556 assay Methods 0.000 title claims abstract description 14
- 238000009396 hybridization Methods 0.000 title claims description 23
- 230000003993 interaction Effects 0.000 title claims description 15
- 239000000523 sample Substances 0.000 claims abstract description 359
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 230
- 238000001514 detection method Methods 0.000 claims abstract description 228
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 227
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 227
- 239000012488 sample solution Substances 0.000 claims abstract description 114
- 239000002773 nucleotide Substances 0.000 claims abstract description 68
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 57
- 238000012360 testing method Methods 0.000 claims abstract description 57
- 230000000295 complement effect Effects 0.000 claims abstract description 19
- 125000006850 spacer group Chemical group 0.000 claims description 77
- 239000003446 ligand Substances 0.000 claims description 44
- 230000027455 binding Effects 0.000 claims description 28
- 238000004458 analytical method Methods 0.000 claims description 14
- 230000009471 action Effects 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 238000004587 chromatography analysis Methods 0.000 claims description 7
- 241000606153 Chlamydia trachomatis Species 0.000 claims description 6
- 229940038705 chlamydia trachomatis Drugs 0.000 claims description 6
- 230000006872 improvement Effects 0.000 claims description 5
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims description 2
- 239000002853 nucleic acid probe Substances 0.000 claims description 2
- HYCSHFLKPSMPGO-UHFFFAOYSA-N 3-hydroxypropyl dihydrogen phosphate Chemical compound OCCCOP(O)(O)=O HYCSHFLKPSMPGO-UHFFFAOYSA-N 0.000 claims 9
- PTMCGHPIYOSATH-UHFFFAOYSA-N hexaethylene glycol monophosphate Chemical compound OCCOCCOCCOCCOCCOCCOP(O)(O)=O PTMCGHPIYOSATH-UHFFFAOYSA-N 0.000 claims 9
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 8
- 238000002331 protein detection Methods 0.000 claims 8
- 229910019142 PO4 Inorganic materials 0.000 claims 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 7
- 239000010452 phosphate Substances 0.000 claims 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 claims 1
- PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 claims 1
- 238000006392 deoxygenation reaction Methods 0.000 claims 1
- 230000002787 reinforcement Effects 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 44
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 52
- 239000011616 biotin Substances 0.000 description 26
- 229960002685 biotin Drugs 0.000 description 26
- 235000020958 biotin Nutrition 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 24
- 239000000975 dye Substances 0.000 description 19
- 230000001745 anti-biotin effect Effects 0.000 description 17
- 239000000203 mixture Substances 0.000 description 14
- 239000000020 Nitrocellulose Substances 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 229920001220 nitrocellulos Polymers 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 108090001008 Avidin Proteins 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 3
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 3
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 3
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 235000004252 protein component Nutrition 0.000 description 3
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
- UWZOVBMIXFYRIJ-UHFFFAOYSA-N 1h-tetrazol-1-ium;phosphate Chemical compound [NH2+]1C=NN=N1.[NH2+]1C=NN=N1.[NH2+]1C=NN=N1.[O-]P([O-])([O-])=O UWZOVBMIXFYRIJ-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000014085 Chronic respiratory disease Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010058683 Immobilized Proteins Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000005582 sexual transmission Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6832—Enhancement of hybridisation reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0016812A GB0016812D0 (en) | 2000-07-07 | 2000-07-07 | Enhancing nucleic acid hybridisation |
| GBGB0016836.9A GB0016836D0 (en) | 2000-07-07 | 2000-07-07 | Improved dipstick assays (1) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TWI286159B true TWI286159B (en) | 2007-09-01 |
Family
ID=26244625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW90116567A TWI286159B (en) | 2000-07-07 | 2001-07-06 | Improved stability of hybridisation interactions in dipstick assays |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2001269292A1 (fr) |
| TW (1) | TWI286159B (fr) |
| WO (1) | WO2002004122A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8669052B2 (en) | 2008-06-10 | 2014-03-11 | Rapid Pathogen Screening, Inc. | Lateral flow nucleic acid detector |
| US20110086359A1 (en) | 2008-06-10 | 2011-04-14 | Rapid Pathogen Screening, Inc. | Lateral flow assays |
| EP2313527A4 (fr) * | 2008-07-15 | 2012-11-21 | Rapid Pathogen Screening Inc | Détecteur d'acide nucléique à flux latéral |
| BR112012009023A2 (pt) * | 2009-10-22 | 2019-09-24 | Biotools Biotechnologial & Medical Laboratories S A | método pra detecção. diferenciação e identificação de eubactérias específica de táxons em uma amostra biológica por meio de técnicas de análise de sequenciamento e kit |
| CN102154498B (zh) * | 2011-03-21 | 2013-12-04 | 厦门大学 | 一种核酸的检测方法 |
| KR20160127753A (ko) | 2014-02-05 | 2016-11-04 | 후소 야쿠힝 고교 가부시끼가이샤 | 마스크 올리고뉴클레오티드를 이용한 핵산의 검출, 정량 방법 및 그 장치 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8509367D0 (en) * | 1985-04-12 | 1985-05-15 | Amersham Int Plc | Nucleic acid hybridisation |
| US4868105A (en) * | 1985-12-11 | 1989-09-19 | Chiron Corporation | Solution phase nucleic acid sandwich assay |
| US5310650A (en) * | 1986-09-29 | 1994-05-10 | Abbott Laboratoires | Method and device for improved reaction kinetics in nucleic acid hybridizations |
| WO1990001564A1 (fr) * | 1988-08-09 | 1990-02-22 | Microprobe Corporation | Procedes d'analyse a cibles multiples par hybridation d'acides nucleiques |
| US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| WO1994023299A1 (fr) * | 1993-03-31 | 1994-10-13 | Quidel Corporation | Dispositif pour dosages multiples |
| WO1994029696A1 (fr) * | 1993-06-09 | 1994-12-22 | Quidel Corporation | Titrages en une etape specifiques d'un antigene |
| WO1995027081A1 (fr) * | 1994-03-31 | 1995-10-12 | E.I. Du Pont De Nemours And Company | Methode de detection de fragments d'acide nucleique |
-
2001
- 2001-07-06 AU AU2001269292A patent/AU2001269292A1/en not_active Abandoned
- 2001-07-06 TW TW90116567A patent/TWI286159B/zh not_active IP Right Cessation
- 2001-07-06 WO PCT/GB2001/003047 patent/WO2002004122A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001269292A1 (en) | 2002-01-21 |
| WO2002004122B1 (fr) | 2003-08-07 |
| WO2002004122A3 (fr) | 2002-12-27 |
| WO2002004122A2 (fr) | 2002-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3418401B2 (ja) | トラコーマ・クラミジア検出のためのオリゴヌクレオチド及び方法 | |
| US20140106347A1 (en) | Binding interactions in dipstick assays | |
| US20080160516A1 (en) | Capture and detection format versatility for dipstick assays | |
| US20150099265A1 (en) | Detection signal and capture in dipstick assays | |
| TWI281501B (en) | Improved capture and detection of target nucleic acid in dipstick assays | |
| AU2001267752A1 (en) | Improved capture and detection of target nucleic acid in dipstick assays | |
| AU2001269285A1 (en) | Improved binding interactions in dipstick assays | |
| AU2001269279A1 (en) | Improved capture and detection format versatility for dipstick assays | |
| AU2001267750A1 (en) | Improved detection signal and capture in dipstick assays | |
| TWI286159B (en) | Improved stability of hybridisation interactions in dipstick assays | |
| KR102149373B1 (ko) | 리프트밸리열바이러스 검출용 프라이머 세트 및 이의 용도 | |
| JPWO2009054320A1 (ja) | 核酸プローブ及びプローブポリマーの形成方法 | |
| JP2021019539A (ja) | 核酸検出方法及びキット | |
| KR102149396B1 (ko) | 한탄바이러스 검출용 프라이머 세트 및 이의 용도 | |
| AU2007234492A1 (en) | Improved detection signal and capture in dipstick assays |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |